Sugi Predict

Sugi Predict / Compounds / SCHEMBL9779396

SCHEMBL9779396

SCHEMBL9779396

O=C(/C=C/c1cccc(C(F)(F)F)c1)c1ccccc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 8/20 0.83
▸ P4HB P07237 3/20 0.79
▸ CYP1B1 Q16678 2/20 0.70
▸ CYP1A1 P04798 1/20 0.70
▸ MAPT P10636 3/20 0.62
▸ LMNA P02545 2/20 0.62
▸ BCHE P06276 2/20 0.62
▸ PLIN1 O60240 1/20 0.62
▸ TNFRSF1A P19438 1/20 0.62
▸ ACHE P22303 1/20 0.62
▸ RECQL P46063 1/20 0.62
▸ PLIN5 Q00G26 1/20 0.62
▸ ABHD5 Q8WTS1 1/20 0.62
▸ MAOA P21397 1/20 0.60
▸ HDAC3 O15379 1/20 0.58
▸ HDAC4 P56524 1/20 0.58
▸ HDAC1 Q13547 1/20 0.58
▸ HDAC7 Q8WUI4 1/20 0.58
▸ HDAC2 Q92769 1/20 0.58
▸ HDAC10 Q969S8 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3032561 1.00 MAOB (0.83) MAOBP4HBCYP1B1CYP1A1MAPT
SCHEMBL2646706 0.92 P4HB (0.76) MAOBP4HBCYP1B1CYP1A1MAPT
SCHEMBL977523 0.91 MAOB (1.00) MAOBP4HBCYP1B1CYP1A1MAPT
SCHEMBL977524 0.91 MAOB (1.00) MAOBP4HBCYP1B1CYP1A1MAPT
SCHEMBL25221835 0.88 P4HB (1.00) MAOBP4HBCYP1B1CYP1A1MAPT
SCHEMBL25199747 0.88 P4HB (1.00) MAOBP4HBCYP1B1CYP1A1MAPT
SCHEMBL15807364 0.87 P4HB (0.78) MAOBP4HBCYP1B1CYP1A1MAPT
SCHEMBL11942091 0.87 P4HB (0.78) MAOBP4HBCYP1B1CYP1A1MAPT
SCHEMBL25217866 0.85 P4HB (0.74) MAOBP4HBCYP1B1CYP1A1MAPT
SCHEMBL17068274 0.84 MAOB (0.68) MAOBP4HBCYP1B1CYP1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105646215-B Process for the preparation of 3-trifluoromethyl chalcones 杜邦公司 2020-04-14 — — CN claimed
US-20250091998-A1 A PROCESS FOR THE PREPARATION OF CARBAMOYL BENZAMIDE PHENYL ISOXAZOLINE CLASS DRUG/S AND ITS INTERMEDIATES ZENFOLD SUSTAINABLE TECHNOLOGIES PRIVATE LIMITED (IN) 2025-03-20 — — US disclosed
CN-117550960-A Process for preparing 1- (3, 5-dichloro-4-fluoro-phenyl) -2, 2-trifluoro-ethanone 先正达参股股份有限公司 2024-02-13 — — CN disclosed
CN-116640100-A Solid-phase synthesis method of fluororalrana 河北圣雪大成制药有限责任公司 2023-08-25 — — CN disclosed
CN-112010732-B Preparation method of 3, 5-dichloro-4-fluorobromobenzene compound 内蒙古永太化学有限公司 2023-07-28 — — CN disclosed
CN-112047804-B Preparation method of 3, 5-dichloro-4-fluorobromobenzene compound 内蒙古永太化学有限公司 2023-06-27 — — CN disclosed
WO-2023012821-A1 A PROCESS FOR THE PREPARATION OF CARBAMOYL BENZAMIDE PHENYL ISOXAZOLINE CLASS DRUG/S AND ITS INTERMEDIATES ZENFOLD SUSTAINABLE TECHNOLOGIES PRIVATE LIMITED (IN) 2023-02-09 — — WO disclosed
CN-112047804-A Preparation method of 3, 5-dichloro-4-fluorobromobenzene compound 内蒙古永太化学有限公司 2020-12-08 — — CN disclosed
CN-112028736-A Preparation method of 3, 5-dichloro-4-fluorobromobenzene compound 内蒙古永太化学有限公司 2020-12-04 — — CN disclosed
CN-112010732-A Preparation method of 3, 5-dichloro-4-fluorobromobenzene compound 内蒙古永太化学有限公司 2020-12-01 — — CN disclosed
US-8217073-B2 Pyrrole derivatives as therapeutic compounds MYREXIS, INC. (US) 2012-07-10 — — US disclosed
US-8217073-B2 Pyrrole derivatives as therapeutic compounds MYREXIS, INC. (US) 2012-07-10 — — US disclosed
US-20100216862-A1 Pyrrole Derivatives As Therapeutic Compounds MYRIAD PHARMACEUTICALS, INC. (US) 2010-08-26 — — US disclosed
US-20100216862-A1 Pyrrole Derivatives As Therapeutic Compounds MYRIAD PHARMACEUTICALS, INC. (US) 2010-08-26 — — US disclosed
US-7714022-B2 Pyrrole derivatives as therapeutic compounds MYRIAD PHARMACEUTICALS, INC. (US) 2010-05-11 — — US disclosed
US-7714022-B2 Pyrrole derivatives as therapeutic compounds MYRIAD PHARMACEUTICALS, INC. (US) 2010-05-11 — — US disclosed
US-20080249158-A1 PYRROLE DERIVATIVES AS THERAPEUTIC COMPOUNDS MYRIAD GENETICS, INCORPORATED (US) 2008-10-09 — — US disclosed
US-20080249158-A1 PYRROLE DERIVATIVES AS THERAPEUTIC COMPOUNDS MYRIAD GENETICS, INCORPORATED (US) 2008-10-09 — — US disclosed
US-5037824-A Cardiotonic, antiischemic agents FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1991-08-06 — — US disclosed
US-3989708-A HYPOTENSIVE, CORONARY VESSEL DILATORS BAYER AKTIENGESELLSCHAFT (DT) 1976-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216862-A1 Pyrrole Derivatives As Therapeutic Compounds APP, PSEN2, PSEN1 MAOB 2093/4885P4HB 3009/4885CYP1B1 4542/4885
US-20250091998-A1 A PROCESS FOR THE PREPARATION OF CARBAMOYL BENZAMIDE PHENYL ISOXAZOLINE CLASS DRUG/S AND ITS INTERMEDIATES CYP3A7, CYP1A2, CYP1B1 MAOB 159/4885P4HB 2531/4885CYP1B1 3/4885
US-20080249158-A1 PYRROLE DERIVATIVES AS THERAPEUTIC COMPOUNDS APP, PSEN2, PSEN1 MAOB 2093/4885P4HB 3009/4885CYP1B1 4542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.